Furthermore, Ge et al. found that EPO/EPOR signaling activates the hepatic AKT pathway by increasing PPARγ expression and activity, which improvements in hepatic insulin resistance (Ge et al. 2015). The gene discussed is AKT1; the disease is Insulin resistance.